company background image
ANPC.Y

ANGLE OTCPK:ANPC.Y Stock Report

Last Price

US$3.55

Market Cap

US$90.8m

7D

-11.2%

1Y

-76.0%

Updated

03 Feb, 2023

Data

Company Financials +

ANPC.Y Stock Overview

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products.

ANPC.Y fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

ANGLE plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ANGLE
Historical stock prices
Current Share PriceUK£3.55
52 Week HighUK£21.00
52 Week LowUK£3.55
Beta0.68
1 Month Change-43.46%
3 Month Change-43.46%
1 Year Change-76.01%
3 Year Change-60.52%
5 Year Changen/a
Change since IPO-73.51%

Recent News & Updates

Recent updates

Shareholder Returns

ANPC.YUS Medical EquipmentUS Market
7D-11.2%4.7%2.9%
1Y-76.0%-8.4%-8.5%

Return vs Industry: ANPC.Y underperformed the US Medical Equipment industry which returned -8.4% over the past year.

Return vs Market: ANPC.Y underperformed the US Market which returned -8.5% over the past year.

Price Volatility

Is ANPC.Y's price volatile compared to industry and market?
ANPC.Y volatility
ANPC.Y Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.8%
10% most volatile stocks in US Market17.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: Insufficient data to determine ANPC.Y's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine ANPC.Y's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994128Andrew David Newlandhttps://angleplc.com

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

ANGLE plc Fundamentals Summary

How do ANGLE's earnings and revenue compare to its market cap?
ANPC.Y fundamental statistics
Market CapUS$90.85m
Earnings (TTM)-US$20.25m
Revenue (TTM)US$1.39m

65.3x

P/S Ratio

-4.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ANPC.Y income statement (TTM)
RevenueUK£1.14m
Cost of RevenueUK£1.04m
Gross ProfitUK£94.00k
Other ExpensesUK£16.64m
Earnings-UK£16.55m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Jun 02, 2023

Earnings per share (EPS)-0.064
Gross Margin8.27%
Net Profit Margin-1,456.87%
Debt/Equity Ratio0%

How did ANPC.Y perform over the long term?

See historical performance and comparison